Hellerstein M K, Munro H N
USDA Human Nutrition Research Center on Aging at Tufts, Boston, MA 02111.
Metabolism. 1988 Apr;37(4):312-7. doi: 10.1016/0026-0495(88)90129-1.
A tracer methodology has been developed for noninvasive assessment of intrahepatic metabolism of administered labeled sugars. In this procedure, we measure the output of the label from the liver in two glycoconjugates derived from hepatic UDP-glucose, namely, glucuronic acid formed through UDP-glucuronic acid and excreted in the urine following acetaminophen administration, and galactose formed through UDP-galactose and then secreted in the carbohydrate portion of glycoproteins in the plasma. Comparison of the distribution of label from various sugar precursors in these end-products can indicate exchanges between hepatic UDP-glucose, UDP-galactose, and UDP-glucuronic acid. In this study we apply the technique to explore whether the enzyme UDP-galactose-4-epimerase catalyzing the step UDP-galactose to UDP-glucose is nonequilibrium and therefore potentially has a regulatory role for utilization of free galactose. The specific activity in the two glycoconjugates was compared when either [1-3H]galactose or [U-14C]glucose was the infused precursor sugar. In rats under a variety of conditions (fasting, oral refeeding, intravenous administration of galactose), label from [1-3H]galactose accumulated in glycoprotein-bound galactose much more than in acetaminophen-bound glucuronic acid, in comparison to label from [U-14C]glucose, demonstrating limitation of the rate of transfer from UDP-galactose to UDP-glucose at the epimerase step. Accordingly, epimerase is suggested to have a regulatory role in the galactose assimilation pathway.(ABSTRACT TRUNCATED AT 250 WORDS)
已开发出一种示踪方法,用于对给予的标记糖在肝内的代谢进行无创评估。在此过程中,我们测量肝脏中源自肝UDP-葡萄糖的两种糖缀合物中标记物的输出,即通过UDP-葡萄糖醛酸形成并在给予对乙酰氨基酚后随尿液排出的葡萄糖醛酸,以及通过UDP-半乳糖形成然后分泌到血浆中糖蛋白碳水化合物部分的半乳糖。比较这些终产物中来自各种糖前体的标记物分布,可以表明肝UDP-葡萄糖、UDP-半乳糖和UDP-葡萄糖醛酸之间的交换情况。在本研究中,我们应用该技术来探究催化UDP-半乳糖向UDP-葡萄糖转化步骤的UDP-半乳糖-4-表异构酶是否处于非平衡状态,因此可能对游离半乳糖的利用具有调节作用。当[1-³H]半乳糖或[U-¹⁴C]葡萄糖作为输注的前体糖时,比较了两种糖缀合物中的比活性。在多种条件下(禁食、口服再喂养、静脉注射半乳糖)的大鼠中,与[U-¹⁴C]葡萄糖的标记物相比,[1-³H]半乳糖的标记物在糖蛋白结合的半乳糖中积累得比对乙酰氨基酚结合的葡萄糖醛酸中多得多,这表明在表异构酶步骤中从UDP-半乳糖向UDP-葡萄糖的转化速率存在限制。因此,提示表异构酶在半乳糖同化途径中具有调节作用。(摘要截短于250字)